My Lords, the vaccine deployment programme is proceeding at pace, for which I give profound thanks on behalf of

all noble Lords. We have offered a Covid vaccine to 15 million of the top four priority cohorts, hitting our 15 February delivery target. We remain on track to achieve our objective of offering a vaccine to all priority cohorts by 15 April and all adults by the end of July.

My Lords, we are on the case. I completely recognise the problems faced by Alfie Dingley and all the individuals reliant on the previous arrangements with the Dutch Government for the supply of Bedrocan oils. The department is working urgently with Dutch Minister Tamara van Ark to find a solution that will enable these patients adequately to access the medications they need, and we are committed to setting up clinical trials to inform future NHS commissioning of cannabis-related medicines.

My Lords, the challenge presented to the dental profession by Covid is severe. We are grateful for the hard work of 10,000 NHS and private practices in introducing PPE and infection-control arrangements to keep patients and staff safe, and to the 600 urgent care centres that are providing services for the most severe cases. However, the impact on the nation’s health remains something that we are working hard to mitigate.

We will set out further details about measures on weight management later in the year.

Through the new obesity strategy, published on 27 July, we are delivering a range of measures on weight management including a National Health Service 12-week weight loss plan app, expanding weight management services to help more people get the support they need, accelerating the expansion of the NHS diabetes prevention programme and making conversations about weight in primary care the norm. Further details about these measures will be available later in the year and we will engage stakeholders throughout this process.

A copy of Tackling obesity: empowering adults and children to live healthier lives is attached.

We are committed to reducing obesity. The National Child Measurement Programme and Health Survey for England provide prevalence data which will be important in understanding the levels of obesity in England. Importantly, alongside reports such as the National Diet and Nutrition Survey which enables us to measure changes to the population’s diet, we will also be putting in place evaluation of our legislative action so we can understand its impact.

Government departments work very closely on reducing obesity and have shared responsibility in delivering these policies.

We are committed to reducing obesity. The National Child Measurement Programme and Health Survey for England provide prevalence data which will be important in understanding the levels of obesity in England. Importantly, alongside reports such as the National Diet and Nutrition Survey which enables us to measure changes to the population’s diet, we will also be putting in place evaluation of our legislative action so we can understand its impact.

Government departments work very closely on reducing obesity and have shared responsibility in delivering these policies.

Through the new obesity strategy, published on 27 July, we are delivering a range of measures on weight management including a National Health Service 12-week weight loss plan app, expanding weight management services to help more people get the support they need, accelerating the expansion of the NHS diabetes prevention programme and making conversations about weight in primary care the norm. Further details about these measures will be available later in the year and we will engage stakeholders throughout this process.

A copy of Tackling obesity: empowering adults and children to live healthier lives is attached.

The costs of medicines associated with treatment sought privately remain the responsibility of patients. No additional public funding is being provided beyond the financial package to provide additional support for public services, individuals and businesses experiencing financial difficulties during COVID-19.

The latest National Institute for Health and Care Excellence guidelines demonstrate a clear need for more evidence to support routine prescribing and funding decisions for unlicensed cannabis-based medicines on the National Health Service, and we are working hard with the health system, industry and researchers to improve the knowledge base.